Last reviewed · How we verify

NCT07017972

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

Recruiting now Last updated 7 August 2025
What this trial tests

trial testing AI evaluation of embryos in Fertility Disorders in 4,000 participants. Currently enrolling.

Timeline
20 June 2025
Primary endpoint
20 June 2027
20 June 2027

Quick facts

Lead sponsorFairtility
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment4,000
Start date20 June 2025
Primary completion20 June 2027
Estimated completion20 June 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Fairtility

Who can join

18 and older, female only, with Fertility Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fertility Disorders

Currently open trials in the same condition.

Other Fairtility trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07017972.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing